| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genetic divergence of the rhesus macaque major histocompatibility complex.
|
Genome Res
|
2004
|
2.32
|
|
2
|
The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.
|
Immunol Rev
|
2002
|
2.21
|
|
3
|
Activation of NK cells by an endocytosed receptor for soluble HLA-G.
|
PLoS Biol
|
2006
|
2.08
|
|
4
|
Reprogramming of CTLs into natural killer-like cells in celiac disease.
|
J Exp Med
|
2006
|
2.03
|
|
5
|
Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.
|
PLoS One
|
2010
|
1.62
|
|
6
|
Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
|
J Virol
|
2006
|
1.62
|
|
7
|
Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition.
|
J Immunol
|
2003
|
1.60
|
|
8
|
Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype.
|
J Virol
|
2010
|
1.39
|
|
9
|
HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities.
|
J Biol Chem
|
2002
|
1.38
|
|
10
|
NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.
|
Blood
|
2010
|
1.38
|
|
11
|
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.
|
J Infect Dis
|
2006
|
1.31
|
|
12
|
Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes.
|
Genomics
|
2006
|
1.28
|
|
13
|
Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics.
|
J Immunol
|
2005
|
1.27
|
|
14
|
Analysis of HLA-E expression in human tumors.
|
Immunogenetics
|
2003
|
1.23
|
|
15
|
Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial.
|
J Infect Dis
|
2011
|
1.20
|
|
16
|
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.
|
J Clin Invest
|
2014
|
1.18
|
|
17
|
High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles.
|
Immunogenetics
|
2007
|
1.17
|
|
18
|
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.
|
Immunogenetics
|
2003
|
1.16
|
|
19
|
Nomenclature for Factors of the HLA System, 2004.
|
Hum Immunol
|
2005
|
1.14
|
|
20
|
HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.
|
J Immunol
|
2013
|
1.05
|
|
21
|
Soluble HLA-G isoforms: technical deficiencies lead to misinterpretations.
|
Mol Hum Reprod
|
2005
|
1.05
|
|
22
|
Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection.
|
J Infect Dis
|
2013
|
1.04
|
|
23
|
HLA-F is a surface marker on activated lymphocytes.
|
Eur J Immunol
|
2010
|
1.03
|
|
24
|
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.
|
Hum Immunol
|
2003
|
1.00
|
|
25
|
HLA-F complex without peptide binds to MHC class I protein in the open conformer form.
|
J Immunol
|
2010
|
0.98
|
|
26
|
Recombinant structures expand and contract inter and intragenic diversification at the KIR locus.
|
BMC Genomics
|
2013
|
0.98
|
|
27
|
HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP.
|
J Immunol
|
2003
|
0.97
|
|
28
|
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.
|
J Immunol
|
2013
|
0.92
|
|
29
|
A soluble isoform of the rhesus monkey nonclassical MHC class I molecule Mamu-AG is expressed in the placenta and the testis.
|
J Immunol
|
2002
|
0.91
|
|
30
|
HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes.
|
Immunogenetics
|
2006
|
0.89
|
|
31
|
Nomenclature for factors of the HLA system, 2002.
|
Hum Immunol
|
2002
|
0.88
|
|
32
|
Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia.
|
Am J Obstet Gynecol
|
2007
|
0.85
|
|
33
|
Nomenclature for factors of the HLA system, 2002.
|
Eur J Immunogenet
|
2002
|
0.81
|
|
34
|
The essential detail: the genetics and genomics of the primate immune response.
|
ILAR J
|
2013
|
0.80
|